Search by Drug Name or NDC

    NDC 43598-0735-22 levocetirizine dihydrochloride 5 mg/1 Details

    levocetirizine dihydrochloride 5 mg/1

    levocetirizine dihydrochloride is a ORAL TABLET, COATED in the HUMAN OTC DRUG category. It is labeled and distributed by Dr. Reddy's Laboratories Inc.. The primary component is LEVOCETIRIZINE DIHYDROCHLORIDE.

    Product Information

    NDC 43598-0735
    Product ID 43598-735_edb4b4ba-4dd4-93b3-d23f-29d2caeccadb
    Associated GPIs 41550027100320
    GCN Sequence Number 048920
    GCN Sequence Number Description levocetirizine dihydrochloride TABLET 5 MG ORAL
    HIC3 Z2Q
    HIC3 Description ANTIHISTAMINES - 2ND GENERATION
    GCN 14901
    HICL Sequence Number 022959
    HICL Sequence Number Description LEVOCETIRIZINE DIHYDROCHLORIDE
    Brand/Generic Generic
    Proprietary Name levocetirizine dihydrochloride
    Proprietary Name Suffix n/a
    Non-Proprietary Name levocetirizine dihydrochloride
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET, COATED
    Route ORAL
    Active Ingredient Strength 5
    Active Ingredient Units mg/1
    Substance Name LEVOCETIRIZINE DIHYDROCHLORIDE
    Labeler Name Dr. Reddy's Laboratories Inc.
    Pharmaceutical Class Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA210375
    Listing Certified Through 2024-12-31

    Package

    NDC 43598-0735-22 (43598073522)

    NDC Package Code 43598-735-22
    Billing NDC 43598073522
    Package 1 BOTTLE in 1 CARTON (43598-735-22) / 55 TABLET, COATED in 1 BOTTLE
    Marketing Start Date 2018-03-12
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 1f722b84-08de-7e6a-41ac-2c9d9bb9fb43 Details

    Revised: 9/2019